Jaro Ankerst

Senior Professor
More filtering options
  1. 2020
  2. 2019
  3. Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease

    Julie Weidner, Prajakta Jogdand, Linnea Jarenbäck, Ida Åberg, Dalja Helihel, Jaro Ankerst, Gunilla Westergren-Thorsson, Leif Bjermer, Jonas S. Erjefält & Ellen Tufvesson, 2019 Jan 13, In: Scientific Reports. 9, 1, 1991.

    Research output: Contribution to journalArticle

  4. 2018
  5. Club cell protein (CC16) in plasma, bronchial brushes, BAL and urine following an inhaled allergen challenge in allergic asthmatics

    Henning Stenberg, Erik Wadelius, Subhabrata Moitra, Ida Åberg, Jaro Ankerst, Zuzana Diamant, Leif Bjermer & Ellen Tufvesson, 2018, In: Biomarkers. 23, 1, p. 51-60

    Research output: Contribution to journalArticle

  6. 2017
  7. Small airway involvement in the late allergic response in asthma

    H. Stenberg, Z. Diamant, J. Ankerst, L. Bjermer & E. Tufvesson, 2017 Dec, In: Clinical and Experimental Allergy. 47, 12, p. 1555-1565

    Research output: Contribution to journalArticle

  8. Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease

    Julie Weidner, Linnea Jarenbäck, Kim de Jong, Judith M Vonk, Maarten van den Berge, Corry Anke Brandsma, H. Marike Boezen, Don D. Sin, Yohan Bossé, David Nickle, Jaro Ankerst, Leif Bjermer, Dirkje S Postma, Alen Faiz & Ellen Tufvesson, 2017 May 2, In: Respiratory Research. 18, 1, 77.

    Research output: Contribution to journalArticle

  9. 2016
  10. 2015
  11. 2014
  12. Oral iodinated activated charcoal improves lung function in patients with COPD.

    Staffan Skogvall, Jonas Erjefält, Anders Olin, Jaro Ankerst & Leif Bjermer, 2014, In: Respiratory Medicine. 108, 6, p. 905-909

    Research output: Contribution to journalArticle

  13. 2013
  14. 2010
  15. After 6 years with Xolair; a 3-year withdrawal follow-up

    A. Nopp, S. G. O. Johansson, J. Adedoyin, Jaro Ankerst, M. Palmqvist & H. Oman, 2010, In: Allergy. 65, 1, p. 56-60

    Research output: Contribution to journalArticle

  16. Xolair Is Effective in Allergics with a Low Serum IgE Level.

    Jaro Ankerst, A Nopp, S G O Johansson, J Adédoyin & H Oman, 2010, In: International Archives of Allergy and Immunology. 152, 1, p. 71-74

    Research output: Contribution to journalArticle

  17. 2009
  18. The size of the disease relevant IgE antibody fraction in relation to 'total-IgE' predicts the efficacy of anti-IgE (Xolair (R)) treatment

    S. G. O. Johansson, A. Nopp, H. Oman, Jaro Ankerst, L. O. Cardell, R. Gronneberg, H. Matsols, S. Rudblad, V. Strand & G. Stalenheim, 2009, In: Allergy. 64, 10, p. 1472-1477

    Research output: Contribution to journalArticle

  19. 2008
  20. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.

    J Lötvall & Jaro Ankerst, 2008, In: Respiratory Medicine. 102, 3, p. 449-456

    Research output: Contribution to journalArticle

  21. Pharmacokinetics of budesonide and formoterol administered via 1 pressurized metered-dose inhaler in patients with asthma and COPD.

    Ann Tronde, Michael Gillen, Lars Borgström, Jan Lötvall & Jaro Ankerst, 2008, In: Journal of Clinical Pharmacology. 48, 11, p. 1300-1308

    Research output: Contribution to journalArticle

  22. Relative systemic availability of budesonide in patients with asthma after inhalation from two dry powder inhalers

    Gunnar Persson, Jaro Ankerst, Michael Gillen, Thomas Bengtsson & Lars Thorsson, 2008, In: Current Medical Research and Opinion. 24, 5, p. 1511-1517

    Research output: Contribution to journalArticle

  23. 2007
  24. CD-sens and clinical changes during withdrawal of Xolair after 6 years of treatment

    A. Nopp, S. G. O. Johansson, Jaro Ankerst, M. Palmqvist & H. Oman, 2007, In: Allergy. 62, 10, p. 1175-1181

    Research output: Contribution to journalArticle

  25. 2006
  26. Basophil allergen threshold sensitivity: a useful approach to anti-IgE treatment efficacy evaluation

    A Nopp, SGO Johansson, Jaro Ankerst, G Bylin, Lars-Olaf Cardell, R Gronneberg, K Irander, M Palmqvist & H Oman, 2006, In: Allergy. 61, 3, p. 298-302

    Research output: Contribution to journalArticle

  27. 2005
  28. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation.

    Monika Malm-Erjefält, Lennart Greiff, Jaro Ankerst, Morgan Andersson, Joanna Wallengren, Lars-Olaf Cardell, S Rak, Carl Persson & Jonas Erjefält, 2005, In: Clinical and Experimental Allergy. 35, 10, p. 1334-1340

    Research output: Contribution to journalArticle

  29. Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler.

    Jaro Ankerst, Jan Lötvall, Sarah Cassidy & Nicola Byrne, 2005, In: Treatments in Respiratory Medicine. 4, 2, p. 123-7

    Research output: Contribution to journalArticle

  30. The effect of formoterol over 24 h in patients with asthma: the role of enantiomers

    J Lotvall, M Palmqvist, Jaro Ankerst, G Persson, J Rosenborg, T Bengtsson, Z Rott, M Poczi, A Devai & B Waldeck, 2005, In: Pulmonary Pharmacology & Therapeutics. 18, 2, p. 109-113

    Research output: Contribution to journalArticle

  31. 2003
  32. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma

    UG Lalloo, J Malolepszy, D Kozma, K Krofta, Jaro Ankerst, B Johansen & NC Thomson, 2003, In: Chest. 123, 5, p. 1480-1487

    Research output: Contribution to journalArticle

  33. Tolerability of a high dose of budesonide/formoterol in a single inhaler in patients with asthma.

    Jaro Ankerst, Gunnar Persson & Eva Weibull, 2003, In: Pulmonary Pharmacology & Therapeutics. 16, 3, p. 147-151

    Research output: Contribution to journalArticle

  34. 2001
  35. Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease

    Anders Andersson, Jaro Ankerst, Arne Lindgren, Kerstin Larsson & Björn Hultberg, 2001, In: Clinical Chemistry and Laboratory Medicine. 39, 3, p. 229-233

    Research output: Contribution to journalArticle

  36. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis

    J Vilsvik, Jaro Ankerst, M Palmqvist, G Persson, J Schaanning, G Schwabe & A Johansson, 2001, In: Respiratory Medicine. 95, 6, p. 484-490

    Research output: Contribution to journalArticle

  37. 1999
  38. Estrogen receptor content in adenovirus type 9-induced rat mammary tumors

    Jaro Ankerst, Mårten Fernö & Nils Jonsson, 1999, In: In Vivo. 13, 2, p. 151-153

    Research output: Contribution to journalArticle

  39. 1993
  40. Laser-induced Fluorescence In Malignant and Normal Tissue of Rats Injected With Benzoporphyrin Derivative

    Stefan Andersson-Engels, J Ankerst, Jonas Johansson, Katarina Svanberg & Sune Svanberg, 1993, In: Photochemistry and Photobiology. 57, 6, p. 978-983

    Research output: Contribution to journalArticle

  41. 1990
  42. Inhibition of platelet aggregation by granulocytes stimulated during experimental trauma

    E. Zoucas, J. Thorne, R. Faldt & J. Ankerst, 1990, In: Critical Care Medicine. 18, 8, p. 845-847

    Research output: Contribution to journalArticle

  43. 1989
  44. Tumour marking properties of different haematoporphyrins and tetrasulfonated phthalocyanine - A comparison

    Stefan Andersson-Engels, J Ankerst, Jonas Johansson, Katarina Svanberg & Sune Svanberg, 1989, In: Lasers in Medical Science. 4, 2, p. 115-123

    Research output: Contribution to journalArticle

  45. 1988
  46. A Comparison of tumor demarcation potential for various hematoporphyrin derivatives and phtalocyanine using laser-induced fluorescence

    S. Andersson-Engels, J. Ankerst, J. Johansson, K. Svanberg & S. Svanberg, 1988 Jun 15, Proceedings of SPIE - The International Society for Optical Engineering. SPIE, Vol. 907. p. 80-86 (Proceedings of SPIE - The International Society for Optical Engineering).

    Research output: Chapter in Book/Report/Conference proceedingPaper in conference proceeding

  47. Aspects of Tumour Demarcation In Rats By Means of Laser-induced Fluorescence and Hematoporphyrin Derivatives

    Stefan Andersson-Engels, J Ankerst, Sune Montan, Katarina Svanberg & Sune Svanberg, 1988, In: Lasers in Medical Science. 3, 4, p. 239-248

    Research output: Contribution to journalArticle

  48. 1987
  49. Inhibition of platelet aggregation by myeloid leukaemic cells demonstrated in vitro

    R. Fäldt, J. Ankerst & E. Zoucas, 1987, In: British Journal of Haematology. 66, 4, p. 529-534 6 p.

    Research output: Contribution to journalArticle

  50. TISSUE CHARACTERIZATION USING LASER-INDUCED FLUORESCENCE.

    P. S. Andersson, S. Montan, S. Svanberg, J. Ankerst, E. Kjellen, L. G. Salford & K. Svanberg, 1987, Conference on Lasers and Electro-Optics. Baltimore,MD, USA: Optical Society of America, Vol. 14. p. 46-48

    Research output: Chapter in Book/Report/Conference proceedingPaper in conference proceeding

  51. Tissue Diagnostics Using Laser-induced Fluorescence Techniques

    Stefan Andersson-Engels, J Ankerst, E Kjellen, Sune Montan, Katarina Svanberg & Sune Svanberg, 1987, In: Berichte der Bunsengesellschaft für Physikalische Chemie. 160, 3, p. 715-721

    Research output: Contribution to journalArticle

  52. 1986
  53. Demonstration of antibodies binding to autologous and allogeneic leukemic cells in childhood ALL - Evidence for a common ALL antigen(s)

    R. Fäldt, J. Ankerst & S. Garwicz, 1986 Jun, In: Blut. 52, 6, p. 337-343

    Research output: Contribution to journalArticle

  54. Use of microcalorimetry in analysing the kinetics of ADCC

    J. Ankerst, H. O. Sjögren & R. Fäldt, 1986 Apr 17, In: Journal of Immunological Methods. 88, 2, p. 259-264

    Research output: Contribution to journalArticle

  55. Fluorescence Studies of Hematoporphyrin Derivative In Normal and Malignant Rat-tissue

    Katarina Svanberg, E Kjellen, J Ankerst, Sune Montan, E Sjoholm & Sune Svanberg, 1986, In: Cancer Research. 46, 8, p. 3803-3808

    Research output: Contribution to journalArticle

  56. 1985
  57. Effect of latex-stimulated granulocytes on platelet aggregation in man

    E. Zoucas, R. Faldt & J. Ankerst, 1985, In: Haemostasis. 15, 3, p. 176-181

    Research output: Contribution to journalArticle

Previous 1 2 Next